Table 1.
Participant Characteristics (N = 264)
Baseline Variables | N | % | M | SD |
---|---|---|---|---|
Age (years) | 15.74 | 1.09 | ||
Diabetes duration (years) | 6.88 | 4.03 | ||
Hemoglobin A1C (%) | 9.14 | 1.92 | ||
Blood glucose monitoring frequency (Daily average over past 14 days) | 3.71 | 2.36 | ||
Gender | ||||
Male | 106 | 40.2 | ||
Female | 158 | 59.8 | ||
Race or ethnicity | ||||
White, non-Hispanic | 173 | 65.5 | ||
African American | 38 | 14.4 | ||
Hispanic | 29 | 11.0 | ||
Asian or Pacific Islander | 6 | 2.3 | ||
Native American or Alaska Native | 3 | 1.1 | ||
Reported as “Other” | 15 | 5.7 | ||
Family income | ||||
Less than $50,000 | 39 | 14.8 | ||
$50,000-$75,000 | 38 | 14.4 | ||
$76,000-$100,000 | 43 | 16.3 | ||
$101,000-$150,000 | 50 | 18.9 | ||
More than $150,000 | 63 | 23.9 | ||
Not reported | 19 | 7.2 | ||
Mother’s education (college graduate) | 162 | 61.4 | ||
Two-parent home | 158 | 59.8 | ||
Intervention assignment | ||||
Resilience | 133 | 50.4 | ||
Education | 131 | 49.6 | ||
Insulin regimen at baseline | ||||
Injections | 79 | 29.9 | ||
Insulin pump | 185 | 70.1 | ||
CGM use at baseline | 80 | 31.3 |